調査レポート | • レポートコード：GIR-2104Z02308 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、血液がん治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。血液がん治療薬の種類別市場規模（血液化学療法薬、血液標的療法薬）、用途別市場規模（白血病、リンパ腫、多発性骨髄腫）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・血液がん治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amgen,、AstraZeneca PLC,、Astellas Pharma,、Bayer AG,、Bristol-Myers Squibb Company,、Celgene Corporation,、Eli Lilly,、F.Hoffmann-La Roche,、Johnson & Johnson,、Novartis、Pfizer,、Takeda Pharmaceutical Company Ltd,、AbbVie ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：血液化学療法薬、血液標的療法薬 ・用途別分析2016年-2026年：白血病、リンパ腫、多発性骨髄腫 ・血液がん治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・血液がん治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・血液がん治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・血液がん治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・血液がん治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Blood Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Blood Cancer Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Blood Cancer Drugs market size is expected to grow at a CAGR of 9.6% for the next five years.
Market segmentation
Blood Cancer Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Blood Chemotherapy Drugs
Blood Targeted Therapy Drugs
Market segment by Application can be divided into
Leukemia
lymphoma
Multiple Myeloma
The key market players for global Blood Cancer Drugs market are listed below:
Amgen,
AstraZeneca PLC,
Astellas Pharma,
Bayer AG,
Bristol-Myers Squibb Company,
Celgene Corporation,
Eli Lilly,
F.Hoffmann-La Roche,
Johnson & Johnson,
Novartis
Pfizer,
Takeda Pharmaceutical Company Ltd,
AbbVie
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Blood Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Blood Cancer Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Blood Chemotherapy Drugs
1.2.3 Blood Targeted Therapy Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Blood Cancer Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Leukemia
1.3.3 lymphoma
1.3.4 Multiple Myeloma
1.4 Global Blood Cancer Drugs Market Size & Forecast
1.4.1 Global Blood Cancer Drugs Sales in Value (2016-2026))
1.4.2 Global Blood Cancer Drugs Sales in Volume (2016-2026)
1.4.3 Global Blood Cancer Drugs Price by Type (2016-2026) & (US$/Unit)
1.5 Global Blood Cancer Drugs Production Capacity Analysis
1.5.1 Global Blood Cancer Drugs Total Production Capacity (2016-2026)
1.5.2 Global Blood Cancer Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Blood Cancer Drugs Market Drivers
1.6.2 Blood Cancer Drugs Market Restraints
1.6.3 Blood Cancer Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Amgen,
2.1.1 Amgen, Details
2.1.2 Amgen, Major Business
2.1.3 Amgen, Blood Cancer Drugs Product and Services
2.1.4 Amgen, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 AstraZeneca PLC,
2.2.1 AstraZeneca PLC, Details
2.2.2 AstraZeneca PLC, Major Business
2.2.3 AstraZeneca PLC, Blood Cancer Drugs Product and Services
2.2.4 AstraZeneca PLC, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Astellas Pharma,
2.3.1 Astellas Pharma, Details
2.3.2 Astellas Pharma, Major Business
2.3.3 Astellas Pharma, Blood Cancer Drugs Product and Services
2.3.4 Astellas Pharma, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Bayer AG,
2.4.1 Bayer AG, Details
2.4.2 Bayer AG, Major Business
2.4.3 Bayer AG, Blood Cancer Drugs Product and Services
2.4.4 Bayer AG, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Bristol-Myers Squibb Company,
2.5.1 Bristol-Myers Squibb Company, Details
2.5.2 Bristol-Myers Squibb Company, Major Business
2.5.3 Bristol-Myers Squibb Company, Blood Cancer Drugs Product and Services
2.5.4 Bristol-Myers Squibb Company, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Celgene Corporation,
2.6.1 Celgene Corporation, Details
2.6.2 Celgene Corporation, Major Business
2.6.3 Celgene Corporation, Blood Cancer Drugs Product and Services
2.6.4 Celgene Corporation, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Eli Lilly,
2.7.1 Eli Lilly, Details
2.7.2 Eli Lilly, Major Business
2.7.3 Eli Lilly, Blood Cancer Drugs Product and Services
2.7.4 Eli Lilly, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 F.Hoffmann-La Roche,
2.8.1 F.Hoffmann-La Roche, Details
2.8.2 F.Hoffmann-La Roche, Major Business
2.8.3 F.Hoffmann-La Roche, Blood Cancer Drugs Product and Services
2.8.4 F.Hoffmann-La Roche, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Johnson & Johnson,
2.9.1 Johnson & Johnson, Details
2.9.2 Johnson & Johnson, Major Business
2.9.3 Johnson & Johnson, Blood Cancer Drugs Product and Services
2.9.4 Johnson & Johnson, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Blood Cancer Drugs Product and Services
2.10.4 Novartis Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Pfizer,
2.11.1 Pfizer, Details
2.11.2 Pfizer, Major Business
2.11.3 Pfizer, Blood Cancer Drugs Product and Services
2.11.4 Pfizer, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Takeda Pharmaceutical Company Ltd,
2.12.1 Takeda Pharmaceutical Company Ltd, Details
2.12.2 Takeda Pharmaceutical Company Ltd, Major Business
2.12.3 Takeda Pharmaceutical Company Ltd, Blood Cancer Drugs Product and Services
2.12.4 Takeda Pharmaceutical Company Ltd, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 AbbVie
2.13.1 AbbVie Details
2.13.2 AbbVie Major Business
2.13.3 AbbVie Blood Cancer Drugs Product and Services
2.13.4 AbbVie Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Blood Cancer Drugs Sales by Manufacturer
3.1 Global Blood Cancer Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Blood Cancer Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Blood Cancer Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Blood Cancer Drugs Manufacturer Market Share
3.4.2 Top 6 Blood Cancer Drugs Manufacturer Market Share
3.5 Global Blood Cancer Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Blood Cancer Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Blood Cancer Drugs Market Size by Region
4.1.1 Global Blood Cancer Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Blood Cancer Drugs Revenue by Region (2016-2026)
4.2 North America Blood Cancer Drugs Revenue (2016-2026)
4.3 Europe Blood Cancer Drugs Revenue (2016-2026)
4.4 Asia-Pacific Blood Cancer Drugs Revenue (2016-2026)
4.5 South America Blood Cancer Drugs Revenue (2016-2026)
4.6 Middle East and Africa Blood Cancer Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Blood Cancer Drugs Sales in Volume by Type (2016-2026)
5.2 Global Blood Cancer Drugs Revenue by Type (2016-2026)
5.3 Global Blood Cancer Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Blood Cancer Drugs Sales in Volume by Application (2016-2026)
6.2 Global Blood Cancer Drugs Revenue by Application (2016-2026)
6.3 Global Blood Cancer Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Blood Cancer Drugs Sales by Type (2016-2026)
7.2 North America Blood Cancer Drugs Sales by Application (2016-2026)
7.3 North America Blood Cancer Drugs Market Size by Country
7.3.1 North America Blood Cancer Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Blood Cancer Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Blood Cancer Drugs Sales by Type (2016-2026)
8.2 Europe Blood Cancer Drugs Sales by Application (2016-2026)
8.3 Europe Blood Cancer Drugs Market Size by Country
8.3.1 Europe Blood Cancer Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Blood Cancer Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Blood Cancer Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Blood Cancer Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Blood Cancer Drugs Market Size by Region
9.3.1 Asia-Pacific Blood Cancer Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Blood Cancer Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Blood Cancer Drugs Sales by Type (2016-2026)
10.2 South America Blood Cancer Drugs Sales by Application (2016-2026)
10.3 South America Blood Cancer Drugs Market Size by Country
10.3.1 South America Blood Cancer Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Blood Cancer Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Blood Cancer Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Blood Cancer Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Blood Cancer Drugs Market Size by Country
11.3.1 Middle East & Africa Blood Cancer Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Blood Cancer Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Blood Cancer Drugs Typical Distributors
12.3 Blood Cancer Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Blood Cancer Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Blood Cancer Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Amgen, Basic Information, Manufacturing Base and Competitors
Table 4. Amgen, Major Business
Table 5. Amgen, Blood Cancer Drugs Product and Services
Table 6. Amgen, Blood Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AstraZeneca PLC, Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca PLC, Major Business
Table 9. AstraZeneca PLC, Blood Cancer Drugs Product and Services
Table 10. AstraZeneca PLC, Blood Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Astellas Pharma, Basic Information, Manufacturing Base and Competitors
Table 12. Astellas Pharma, Major Business
Table 13. Astellas Pharma, Blood Cancer Drugs Product and Services
Table 14. Astellas Pharma, Blood Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bayer AG, Basic Information, Manufacturing Base and Competitors
Table 16. Bayer AG, Major Business
Table 17. Bayer AG, Blood Cancer Drugs Product and Services
Table 18. Bayer AG, Blood Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Bristol-Myers Squibb Company, Basic Information, Manufacturing Base and Competitors
Table 20. Bristol-Myers Squibb Company, Major Business
Table 21. Bristol-Myers Squibb Company, Blood Cancer Drugs Product and Services
Table 22. Bristol-Myers Squibb Company, Blood Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Celgene Corporation, Basic Information, Manufacturing Base and Competitors
Table 24. Celgene Corporation, Major Business
Table 25. Celgene Corporation, Blood Cancer Drugs Product and Services
Table 26. Celgene Corporation, Blood Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Eli Lilly, Basic Information, Manufacturing Base and Competitors
Table 28. Eli Lilly, Major Business
Table 29. Eli Lilly, Blood Cancer Drugs Product and Services
Table 30. Eli Lilly, Blood Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. F.Hoffmann-La Roche, Basic Information, Manufacturing Base and Competitors
Table 32. F.Hoffmann-La Roche, Major Business
Table 33. F.Hoffmann-La Roche, Blood Cancer Drugs Product and Services
Table 34. F.Hoffmann-La Roche, Blood Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Johnson & Johnson, Basic Information, Manufacturing Base and Competitors
Table 36. Johnson & Johnson, Major Business
Table 37. Johnson & Johnson, Blood Cancer Drugs Product and Services
Table 38. Johnson & Johnson, Blood Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Novartis Basic Information, Manufacturing Base and Competitors
Table 40. Novartis Major Business
Table 41. Novartis Blood Cancer Drugs Product and Services
Table 42. Novartis Blood Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Pfizer, Basic Information, Manufacturing Base and Competitors
Table 44. Pfizer, Major Business
Table 45. Pfizer, Blood Cancer Drugs Product and Services
Table 46. Pfizer, Blood Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Takeda Pharmaceutical Company Ltd, Basic Information, Manufacturing Base and Competitors
Table 48. Takeda Pharmaceutical Company Ltd, Major Business
Table 49. Takeda Pharmaceutical Company Ltd, Blood Cancer Drugs Product and Services
Table 50. Takeda Pharmaceutical Company Ltd, Blood Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. AbbVie Basic Information, Manufacturing Base and Competitors
Table 52. AbbVie Major Business
Table 53. AbbVie Blood Cancer Drugs Product and Services
Table 54. AbbVie Blood Cancer Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Blood Cancer Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 56. Global Blood Cancer Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Blood Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Blood Cancer Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Blood Cancer Drugs Production Site of Key Manufacturer
Table 60. Global Blood Cancer Drugs Sales by Region (2016-2021e) & (K Units)
Table 61. Global Blood Cancer Drugs Sales by Region (2021-2026) & (K Units)
Table 62. Global Blood Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 63. Global Blood Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 64. Global Blood Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 65. Global Blood Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 66. Global Blood Cancer Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 67. Global Blood Cancer Drugs Revenue by Type (2021-2026) & (USD Million)
Table 68. Global Blood Cancer Drugs Price by Type (2016-2021e) & (US$/Unit)
Table 69. Global Blood Cancer Drugs Price by Type (2021-2026) & (US$/Unit)
Table 70. Global Blood Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 71. Global Blood Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 72. Global Blood Cancer Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 73. Global Blood Cancer Drugs Revenue by Application (2021-2026) & (USD Million)
Table 74. Global Blood Cancer Drugs Price by Application (2016-2021e) & (US$/Unit)
Table 75. Global Blood Cancer Drugs Price by Application (2021-2026) & (US$/Unit)
Table 76. North America Blood Cancer Drugs Sales by Country (2016-2021e) & (K Units)
Table 77. North America Blood Cancer Drugs Sales by Country (2021-2026) & (K Units)
Table 78. North America Blood Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 79. North America Blood Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 80. North America Blood Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 81. North America Blood Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 82. North America Blood Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 83. North America Blood Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 84. Europe Blood Cancer Drugs Sales by Country (2016-2021e) & (K Units)
Table 85. Europe Blood Cancer Drugs Sales by Country (2021-2026) & (K Units)
Table 86. Europe Blood Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. Europe Blood Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. Europe Blood Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 89. Europe Blood Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 90. Europe Blood Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 91. Europe Blood Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 92. Asia-Pacific Blood Cancer Drugs Sales by Region (2016-2021e) & (K Units)
Table 93. Asia-Pacific Blood Cancer Drugs Sales by Region (2021-2026) & (K Units)
Table 94. Asia-Pacific Blood Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 95. Asia-Pacific Blood Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific Blood Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 97. Asia-Pacific Blood Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 98. Asia-Pacific Blood Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 99. Asia-Pacific Blood Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 100. South America Blood Cancer Drugs Sales by Country (2016-2021e) & (K Units)
Table 101. South America Blood Cancer Drugs Sales by Country (2021-2026) & (K Units)
Table 102. South America Blood Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 103. South America Blood Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 104. South America Blood Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 105. South America Blood Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 106. South America Blood Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 107. South America Blood Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 108. Middle East & Africa Blood Cancer Drugs Sales by Country (2016-2021e) & (K Units)
Table 109. Middle East & Africa Blood Cancer Drugs Sales by Country (2021-2026) & (K Units)
Table 110. Middle East & Africa Blood Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 111. Middle East & Africa Blood Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Blood Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 113. Middle East & Africa Blood Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 114. Middle East & Africa Blood Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 115. Middle East & Africa Blood Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Blood Cancer Drugs Typical Distributors
Table 119. Blood Cancer Drugs Typical Customers
List of Figures
Figure 1. Blood Cancer Drugs Picture
Figure 2. Global Blood Cancer Drugs Sales Market Share by Type in 2020
Figure 3. Blood Chemotherapy Drugs
Figure 4. Blood Targeted Therapy Drugs
Figure 5. Global Blood Cancer Drugs Sales Market Share by Application in 2020
Figure 6. Leukemia
Figure 7. lymphoma
Figure 8. Multiple Myeloma
Figure 9. Global Blood Cancer Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Blood Cancer Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Blood Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Blood Cancer Drugs Sales (2016-2026) & (K Units)
Figure 31. Global Blood Cancer Drugs Production Capacity (2016-2026) & (K Units)
Figure 32. Global Blood Cancer Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Blood Cancer Drugs Market Drivers
Figure 34. Blood Cancer Drugs Market Restraints
Figure 35. Blood Cancer Drugs Market Trends
Figure 36. Global Blood Cancer Drugs Sales Market Share by Manufacturer in 2020
Figure 37. Global Blood Cancer Drugs Revenue Market Share by Manufacturer in 2020
Figure 38. Blood Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Blood Cancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Blood Cancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Blood Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 42. Global Blood Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 43. North America Blood Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 44. Europe Blood Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Blood Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 46. South America Blood Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Blood Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Global Blood Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 49. Global Blood Cancer Drugs Revenue Market Share by Type (2016-2026)
Figure 50. Global Blood Cancer Drugs Price by Type (2016-2026) & (US$/Unit)
Figure 51. Global Blood Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 52. Global Blood Cancer Drugs Revenue Market Share by Application (2016-2026)
Figure 53. Global Blood Cancer Drugs Price by Application (2016-2026) & (US$/Unit)
Figure 54. North America Blood Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 55. North America Blood Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 56. North America Blood Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 57. North America Blood Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 58. Europe Blood Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 59. Europe Blood Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 60. Europe Blood Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 61. Europe Blood Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Blood Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Blood Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Blood Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Blood Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 66. South America Blood Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 67. South America Blood Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 68. South America Blood Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 69. South America Blood Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Blood Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Blood Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Blood Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Blood Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の抗凝血治療薬市場 2021：企業別、地域別、種類・用途別 The Blood-thinning Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…- 世界の高血圧治療薬（高血圧症）市場 2021：企業別、地域別、種類・用途別 The High Blood Pressure Drugs (Hypertension) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung Cancer Treatment Drugs are durgs used to cure lung cancer. In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing…
- 世界の抗がん剤市場 2021：企業別、地域別、種類・用途別 The Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recen…
- 世界の尿路上皮がん治療薬市場 2021：企業別、地域別、種類・用途別 The Urothelial Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…